Improving Anti-PD-1/PD-L1 Therapy for Localized Bladder Cancer

In high-risk non-muscle invasive bladder cancer (HR-NMIBC), patient outcome is negatively affected by lack of response to Bacillus-Calmette Guérin (BCG) treatment. Lack of response to cisplatin-based neoadjuvant chemotherapy and cisplatin ineligibility reduces successful treatment outcomes in muscle...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Int J Mol Sci
Main Authors: de Jong, Florus C., Rutten, Vera C., Zuiverloon, Tahlita C. M., Theodorescu, Dan
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2021
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7998260/
https://ncbi.nlm.nih.gov/pubmed/33802033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22062800
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki